摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Triphenyl-(3-trimethylsilanyloxy-propylidene)-λ5-phosphane | 110370-82-6

中文名称
——
中文别名
——
英文名称
Triphenyl-(3-trimethylsilanyloxy-propylidene)-λ5-phosphane
英文别名
triphenyl(3-trimethylsilyloxypropylidene)-λ5-phosphane
Triphenyl-(3-trimethylsilanyloxy-propylidene)-λ<sup>5</sup>-phosphane化学式
CAS
110370-82-6
化学式
C24H29OPSi
mdl
——
分子量
392.553
InChiKey
HVOANDVQGGOPBW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    489.7±47.0 °C(Predicted)
  • 密度:
    1.05±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.02
  • 重原子数:
    27.0
  • 可旋转键数:
    7.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    9.23
  • 氢给体数:
    0.0
  • 氢受体数:
    1.0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    通过区域和立体选择性四氢呋喃环形成策略合成黏液毒素的拟议结构
    摘要:
    描述了提议的粘蛋白(1)结构的对映选择性全合成。粘液毒素是一种从卷花粘膜的生物活性叶片提取物中分离出来的无水产乙酸素,它是第一种含有羟基化三取代四氢呋喃(THF)环的产乙酸素。此天然产物是一种高度有效的和特异性的抗肿瘤抗MCF-7(乳腺癌)细胞系剂(ED 50 = 3.7×10 - 3微克/毫升相比阿霉素,ED 50 = 1.0×10 - 2微克/毫升)。本文所述的总合成具有两个区域选择性和立体选择性的THF成环反应。2,3,5-三取代的THF部分(C13-C17)使用亚甲基间断的环氧二醇的高度区域选择性环化获得,2,5,5-二取代的THF环(C8-C12)可以通过1方便地组装2-正三醇环化策略。合成材料及其两个非对映异构体的光谱数据与天然产物的报道数据不匹配。在对合成分子进行详细的光谱分析的基础上,我们认为光谱差异是由于天然产物的立体化学错配引起的。
    DOI:
    10.1021/jo052073c
  • 作为产物:
    参考文献:
    名称:
    通过区域和立体选择性四氢呋喃环形成策略合成黏液毒素的拟议结构
    摘要:
    描述了提议的粘蛋白(1)结构的对映选择性全合成。粘液毒素是一种从卷花粘膜的生物活性叶片提取物中分离出来的无水产乙酸素,它是第一种含有羟基化三取代四氢呋喃(THF)环的产乙酸素。此天然产物是一种高度有效的和特异性的抗肿瘤抗MCF-7(乳腺癌)细胞系剂(ED 50 = 3.7×10 - 3微克/毫升相比阿霉素,ED 50 = 1.0×10 - 2微克/毫升)。本文所述的总合成具有两个区域选择性和立体选择性的THF成环反应。2,3,5-三取代的THF部分(C13-C17)使用亚甲基间断的环氧二醇的高度区域选择性环化获得,2,5,5-二取代的THF环(C8-C12)可以通过1方便地组装2-正三醇环化策略。合成材料及其两个非对映异构体的光谱数据与天然产物的报道数据不匹配。在对合成分子进行详细的光谱分析的基础上,我们认为光谱差异是由于天然产物的立体化学错配引起的。
    DOI:
    10.1021/jo052073c
点击查看最新优质反应信息

文献信息

  • Total Syntheses of (+)-Australine and (−)-7-Epialexine
    作者:William H. Pearson、Jennifer V. Hines
    DOI:10.1021/jo000689q
    日期:2000.9.1
    naturally occurring 3-(hydroxymethyl)pyrrolizidines. A third approach to these compounds was successful. The transformation of L-xylose into the azido epoxy tosylate 46 was accomplished using two Wittig reactions and an epoxidation, in addition to other standard functional group manipulations. Reductive double-cyclization of 46 afforded the pyrrolizidines 47a and 47b, which were debenzylated to afford
    研究了三种合成3-(羟甲基)吡咯烷核苷的方法,3-类化合物包括多羟基化的吡咯烷啶生物碱alexine(1),australine(2)及其各种立体异构体。在第一种方法中,将叠氮化物分子内环加成到带有末端烷氧基甲基取代基(即21)的富电子的1,3-二烯上,得到脱氢吡咯烷核苷22a和22b,其中22a占优势。提出了这种立体选择性的基本原理。由于将苯基乙烯基硫醚官能团转化成其他有用的官能团遇到困难,因此不可能将主要的非对映异构体22a转化成天然的3-(羟甲基)吡咯烷啶。研究了第二种方法,其中发现叠氮化物与光学纯的St-Bu-取代的二烯(即30)的分子内环加成产生吡咯并核苷31。在这种情况下,烷氧基甲基取代基并入叠氮化物和二烯之间的系链中,而不是二烯本身。二烯30合成中的关键转化是使用烯丙基硼烷R(2)BCH(2)CH = C(TMS)(StBu)将D-阿拉伯糖衍生的叠氮基醛28立体选择性转化为苯
  • A Concise Synthesis of (−)-Aplyviolene Facilitated by a Strategic Tertiary Radical Conjugate Addition
    作者:Martin J. Schnermann、Larry E. Overman
    DOI:10.1002/anie.201204977
    日期:2012.9.17
    A second‐generation synthesis of the rearranged spongian diterpene aplyviolene is reported. The key step is the addition of a trialkyl tertiary radical generated by photoredox‐mediated fragmentation of a N‐(acyloxy)phthalimide to an α‐chloropentenone (see scheme). This process fashioned a quaternary stereocenter while combining two units of significant complexity.
    报道了重排海绵二萜 aplyviolene 的第二代合成。关键步骤是将通过光氧化还原介导的N-(酰氧基)邻苯二甲酰亚胺碎裂生成的三烷基叔自由基添加到 α-戊烯酮上(参见方案)。这个过程形成了一个四元立体中心,同时结合了两个非常复杂的单元。
  • Palladium-catalyzed stereocontrolled cyclization of 1,3-diene monoepoxide: A route to a new synthetic intermediate for de-ab-cholestane derivative.
    作者:Takashi Takahashi、Masahiro Miyazawa、Hiroaki Ueno、Jiro Tsuji
    DOI:10.1016/s0040-4039(00)83905-2
    日期:1986.1
    The optically active (2R, 3R)-3-[(3R)-(E)-Benzyloxymethoxy-5-methyl-1-hexenyl]-2-(3-butenyl)-2-methyl-1-cyclopentanone (8) was synthesized as a precursor of vitamin D3(5) by palladium-catalyzed syn-SN2′ cyclization of [Z,Z(22S, 23R)]-ene oxide 6 as a key reaction.
    旋光的(2R,3R)-3-[(3R)-(E)-苄氧基甲氧基-5-甲基-1-己烯基] -2-(3-丁烯基)-2-甲基-1-环戊酮(8)为通过催化的[Z,Z(22S,23R)]-氧化烯6的syn-S N 2'环化反应合成维生素D 3(5)的前体。
  • Samarium(II) Iodide-Mediated Reductive Annulations of Ketones Bearing a Distal Vinyl Epoxide Moiety
    作者:Gary A. Molander、Sagar R. Shakya
    DOI:10.1021/jo960335s
    日期:1996.1.1
    Samarium(II) iodide in the presence of hexamethylphosphoramide (HMPA) efficiently promotes the intramolecular coupling of ketones with distal epoxy olefins. The reaction appears to proceed by a mechanism wherein a ketyl couples with the unsaturated epoxide. Subsequent fragmentation of the epoxide ring in compounds 1a-k yields carbocycles 2a-k with an allyl alcohol side chain in good yields, and often with high diastereoselectivity. When tetramethylguanidine was used as an additive instead of HMPA, the desired carbocycle was obtained in good yield, but the diastereoselectivity was diminished. A palladium(0)-catalyzed SmI2 reaction provided the expected product in modest yield, but the sense of diastereoselectivity was reversed. In the latter case, a different reaction mechanism may be involved. Thus, formation of an allylsamarium species may be invoked, with nucleophilic carbonyl addition leading to the observed facial selectivity.
  • Synthesis of (-)-slaframine and related indolizidines
    作者:William H. Pearson、Stephen C. Bergmeier、John P. Williams
    DOI:10.1021/jo00040a045
    日期:1992.7
    An enantioselective synthesis of the indolizidine alkaloid (-)-slaframine 1 is reported. Reductive double cyclization of the azido epoxy tosylate 48 afforded the indolizidine 52, which was converted to (-)-slaframine in two steps. The cyclization substrate 48 was prepared in optically pure form from L-glutamic acid. A similar sequence starting with the epoxide 49 allowed the synthesis of (-)-1,8a-diepislaframine 56. Other routes to slaframine were investigated, often using an intramolecular cycloaddition of an azide with an alkene as a key step. Although these routes did not produce slaframine, they illustrated novel and efficient methods for the assembly of the indolizidine skeleton. Cyclization of the azidodiene 20 afforded the indolizidine 21 in one step as a single diastereomer, presumably a result of a chairlike transition state in the initial dipolar cycloaddition. Desulfurization and deprotection produced (-)-8a-epidesacetoxyslaframine 27. Cyclopropylimine rearrangement of 30 gave the indolizidine 31, which was also converted into (-)-8a-epidesacetoxyslaframine 27. Dipolar cycloaddition of 38 gave the 1-pyrroline 39, which was converted to the indolizidine 40 in one operation using Evans' double alkylation of the 1-metalloenamine derivative of 40. Attempted oxidation of 40 to the ketone 41 was unsuccessful, precluding a reductive amination approach to slaframine.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫